Lungs Breath Easy

Safety First:

Risks Involved With ALLOGENIC (Cells NOT from your body) Stem Cell Therapy While additional research is underway to further assess the safety and efficacy of stem cell treatment for COPD and other diseases, there are certain risks that have been clearly identified, primarily with ALLOGENIC (Cells NOT from your body) stem cell


Lung Disease Information

Yes. There is Hope

Rejuvenare’s medical board reviews every case to qualify a prospective patient. You will NOT be invited for treatment unless we feel strongly you will benefit from SCT. We reject all prospects that will not meet our criteria. We have treated over 400 COPD patients safely and efficaciously, utilizing our proprietary cell processing protocols and consistently meeting or exceeding our therapeutic expectations.

Rejuvenare’s proprietary processing of the stem cells has now consistently achieved the therapeutic expectations. However, that is just 50% of the therapy. The other 50% is the delivery protocols from our pioneer doctors tested, adjusted, and retested to reach the desired optimized therapeutic effect.

Stem Cell Therapy For Lung Disease

Most of our COPD patients require a single implant of cells to achieve the therapeutic effect; however for no-option patients and pulmonary fibrosis patients we strongly suggest a minimum of two implants, regardless of how well they feel after the first SCT.

There is no down time as all is done with local anesthesia.

The ready-processed cells are delivered directly to the arm vein following Rejuvenare’s revolutionary delivery protocols.

Stem Cell therapy starts after a 20-minute harvesting procedure of adult stem cells from the patient’s Adipose (Mesenchymal Stem Cells and Endothelial Progenitor Cells, CD34+) via small liposuction performed with local anesthesia and conscious sedation. The adipose tissue is then processed by the Tissue Genesis ICellator, a state of the art, single-use, sterile, automated system that isolates a potent and pure mixture of mesenchymal stem cells and endothelial progenitor cells that have the ability to heal/repair/help the damaged heart tissue by minimizing inflammation, preventing further cardiac cell death and inducing the growth and proliferation of new blood vessels that enhance tissue perfusion. We deliver stem cells into the main vein of the heart through a cardiac catheterization procedure done in our state-of-the-art catheterization lab. This procedure only affects the patient’s veins; therefore, minimal recovery is necessary and only immediately after the procedure.

What does stem cell therapy do for COPD?

Adult stem cells can be thought of as “small doctors” that live inside our bodies taking care of normal every day wear-and-tear bumps and bruises. Their job is to heal and repair the body on a daily basis creating and regenerating tissue. For example, if you cut your finger, it is these cells that will tend to the wound and create new skin.

Although our lungs possess their own population of healing adult stem cells, there are simply not enough cells present in that location to keep up with the degree of ongoing lung tissue damage that occurs in COPD.

As backed by years of research and Rejuvenare’s own experience, stem cells harvested from the adipose tissue, and later processed in our lab creates the most potent Stem Cells ready for implantation which can be immediately put to work to provide cellular repair to the damage found in lungs as a result of COPD.

Once your own processed healing cells are implanted many things will happen at once; They will target and generally stop the slow the degenerative progression of COPD while at the same time restoring normal blood flow, drastically reducing inflammation throughout the system and regenerating tissue all at the same time.

Shortly after implantation and when results start showing, essentially making it easier for the patient to breathe, quality of life improves in the form of:

• Breathing becomes easier
• Energy and stamina increases
• Bronchial infections become less frequent

Most of our COPD patients require a single implant of cells to achieve the therapeutic effect; however, for non-option patients and pulmonary fibrosis patients, we strongly suggest a minimum of two implants, regardless of how well they feel after the first SCT.

Side Effects – We have not seen any ill side effects, only overall improvements of other unrelated conditions. We strive to educate our patients for them to understand what to expect from treatment.

Contact Us

If you would like to request information on treatment, please click the button below to fill out a quick questionnaire. You’ll be paired with a specialist, knowledgeable in all aspects of our therapies, and you’ll be contacted to discuss your needs shortly.

Contact Us
Complimentary Evaluation!